ID: ALA5271313

Max Phase: Preclinical

Molecular Formula: C21H18FN5O2

Molecular Weight: 391.41

Representations

Canonical SMILES:  COc1cc(F)cc2c(N3CCN4c5ccccc5OC[C@H]4C3)c(C#N)nnc12

Standard InChI:  InChI=1S/C21H18FN5O2/c1-28-19-9-13(22)8-15-20(19)25-24-16(10-23)21(15)26-6-7-27-14(11-26)12-29-18-5-3-2-4-17(18)27/h2-5,8-9,14H,6-7,11-12H2,1H3/t14-/m1/s1

Standard InChI Key:  PAGHJJMXITYTPR-CQSZACIVSA-N

Molecule Features

Natural Product: No

Oral: No

Chemical Probe: No

Parenteral: No

Molecule Type:

Topical: No

First In Class: No

Black Box: No

Chirality: No

Availability: No

Prodrug: No

Properties

Molecular Weight: 391.41

Molecular Weight (Monoisotopic): 391.1445

AlogP: 2.74

#Rotatable Bonds: 2

Polar Surface Area: 74.51

Molecular Species: NEUTRAL

HBA: 7

HBD: 0

#RO5 Violations: 0

HBA (Lipinski): 7

HBD (Lipinski): 0

#RO5 Violations (Lipinski): 0

CX Acidic pKa:

CX Basic pKa: 1.41

CX LogP: 2.95

CX LogD: 2.95

Aromatic Rings: 3

Heavy Atoms: 29

QED Weighted: 0.66

Np Likeness Score: -1.23

References

1. Kalbfleisch JJ, Rodriguez AL, Lei X, Weiss K, Blobaum AL, Boutaud O, Niswender CM, Lindsley CW..  (2023)  Persistent challenges in the development of an mGlu₇ PAM in vivo tool compound: The discovery of VU6046980.,  80  [PMID:36528230] [10.1016/j.bmcl.2022.129106]

Source

Source(1):

• Scientific Literature